Literature DB >> 23703486

[Prevalence of selected musculoskeletal conditions in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

J Fuchs1, M Rabenberg, C Scheidt-Nave.   

Abstract

The term musculoskeletal condition (MSKC) comprises inflammatory and degenerative diseases of joints and bones. They are among the most common conditions in older age and cause of severe long-term pain, physical disability, and decrease in quality of life. Data from the German Health Interview and Examination Survey for Adults (DEGS1) were used to estimate the life-time prevalence of osteoarthritis, rheumatoid arthritis (RA) and osteoporosis in Germany. A total of 7,988 persons aged 18-79 years (osteoporosis 50-79 years) were asked to report doctor-diagnosed MSKC in face-to-face interviews. Women were more likely to report all MSKC and all prevalences increase with age. Osteoarthritis is reported by 22.3 % of women and 18.1 % of men, RA by 3.2 % of women and 1.9 % of men, and osteoporosis by 13.1 % of women and 3.2 % of men. MSKC are of great relevance for older adults in Germany. Data from DEGS1 provide a lot of information along to MSKC and hereby allow a closer description of the health situation of older adults. An English full-text version of this article is available at SpringerLink as supplemental.

Entities:  

Mesh:

Year:  2013        PMID: 23703486     DOI: 10.1007/s00103-013-1687-4

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  18 in total

1.  [Differences in chronic back pain and joint disorders among health insurance funds : Results of a cross-sectional study based on the data of the Socioeconomic Panel from 2013].

Authors:  A Luque Ramos; F Hoffmann
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

Review 2.  [Quality criteria in arthroplasty].

Authors:  Max Jaenisch; Karl Dieter Heller; Dieter Christian Wirtz
Journal:  Chirurg       Date:  2021-07-23       Impact factor: 0.955

Review 3.  [Treatment of degenerative meniscal lesions : From eminence to evidence-based medicine].

Authors:  R Becker; M Bernard; S Scheffler; S Kopf
Journal:  Orthopade       Date:  2017-10       Impact factor: 1.087

4.  [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg].

Authors:  A Strahl; O Schneider; J Frankenhauser-Mannuß; S Knapstein; C Hermann; B Lembeck; H-M Lorenz; W Rüther; J Flechtenmacher
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

5.  [Knee joint pain with signs of arthrosis].

Authors:  T T A Bender; M Marinova; L Radbruch; R Conrad; D Jobst; M Mücke
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

6.  Pain, social support and depressive symptoms in patients with rheumatoid arthritis: testing the stress-buffering hypothesis.

Authors:  Susanne Brandstetter; Gertraud Riedelbeck; Mark Steinmann; Boris Ehrenstein; Julika Loss; Christian Apfelbacher
Journal:  Rheumatol Int       Date:  2017-01-25       Impact factor: 2.631

Review 7.  [Gender-specific differences in comorbidities of rheumatoid arthritis].

Authors:  K Albrecht
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

8.  Evaluating the consequences of rheumatoid arthritis.

Authors:  Björn Sossong; Stefan Felder; Malte Wolff; Klaus Krüger
Journal:  Eur J Health Econ       Date:  2016-07-28

9.  [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].

Authors:  S Hense; A Luque Ramos; J Callhoff; K Albrecht; A Zink; F Hoffmann
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

Review 10.  [Endoprosthetic treatment of osteoporosis-related coxarthrosis : aspects of safe patient treatment].

Authors:  S Kirschner; A Hartmann; K-P Günther; C Hamann
Journal:  Orthopade       Date:  2014-04       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.